Ajouter à une liste

Instrument Inactif

Communiqués Starflick.com OTC Bulletin Board

Actions

US85529D2036

Installations et services en soins de santé

Cours en clôture OTC Bulletin Board Autres places de cotation
- ^USD	-

16/02/23	Lotus Bio-Technology Development Corp. (OTCPK:LBTD) a acquis Pioneer Digital Health, Inc.	CI
25/10/22	BioGnomics Lab, LLC a acquis Boomerangkit.com, LLC de Lotus Bio-Technology Development Corp. (OTCPK:LBTD).	CI

Communiqués

16/02/23	Lotus Bio-Technology Development Corp. Increases Their Footprint in the Fast-Growing Digital Health and Wellness Home Testing Markets with the Acquisition of Pioneer Digital Health	AQ
25/10/22	Lotus Bio-Technology Development Corp. announces sale of Boomerangkit.com, LLC	PR
30/08/22	Lotus Bio-Technology Development Corp. Releases Shareholder Update Addressing Securities and Exchange Commission's Complaint	PR
19/08/22	Lotus Bio Technology Development : Current Report	PU
16/08/22	Lotus Bio-Technology Development Corp, Inc. Initiates Company Name Change	PR
16/08/22	Lotus Bio-Technology Development Corp, Inc , Announces Resignation of Director and Surrendering of 150,000,000 Common Shares to Treasury.	PR
02/08/22	Lotus Bio-Technology Development Corp. Announces YTD Revenues And Projections by The Newly Acquired Companies in The Digital Health And Wellness Home Testing Industry.	AQ
06/07/22	Lotus Bio-Technology Development Corp. Enters Fast-Growing Digital Health and Wellness Home Testing Markets with the Acquisition of Focal Point, Inc. and Boomerangkit.com, LLC.	AQ
30/06/22	Lotus Bio Technology Development : Attorney Letter with Respect to Current Information	PU
13/04/22	Lotus Bio-Technology Development Corp. (OTC: LBTD) (“LBTD”) Announces Entering Into a Binding Letter of Intent	AQ
07/04/21	Lotus Bio Technology Development : BIOTECH DEVELOPMENT CORP. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATION. (form 10-Q/A)	AQ
23/02/21	Lotus Bio Technology Development : BIOTECH DEVELOPMENT CORP. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATION. (form 10-Q/A)	AQ
27/01/21	Lotus Bio Technology Development : BIOTECH DEVELOPMENT CORP. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATION. (form 10-Q/A)	AQ
21/01/21	Lotus Bio Technology Development : BIOTECH DEVELOPMENT CORP. - 10-K/A - MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATION.	AQ

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Articles Zonebourse Analyses Zonebourse

Filtres

DERNIÈRES HEURES | -40% : Les Meilleurs Outils Réservés aux Abonnés pour Identifier les Meilleurs Investissements de Demain !

PROFITEZ-EN MAINTENANT